Website Allander Biotechnologies is developing a first-in-class topical therapeutic that rapidly penetrates cells at the site of injury or irritation. It modulates multiple pathogenic pathways to treat oral mucositis, atopic dermatitis, and other inflammatory disorders.
Website Vona Oncology is an early clinical stage bio-pharmaceutical company developing targeted therapeutics to treat aggressive cancers such as triple-negative breast cancer (TNBC), ovarian cancer, and melanoma. TNBC is the initial indication for Vona’s small molecule drug, VDX-111.
Website RefinedScience is a precision medicine company arising from the Innovation Centers at the University of Colorado Anschutz Medical Campus and UCHealth. It is devoted to identifying novel cellular targets as well as promising and safe new agents against treatment resistant cancers and other diseases. It accomplishes this by mining big data sets comprised of…
Website OncoVerity is pioneering the use of a proprietary precision medicine platform to better the lives of patients battling cancer. OncoVerity’s approach leverages the University of Colorado Anschutz Medical Campus and UCHealth infrastructure in single-cell multi-omics analysis and machine learning alongside one of the most comprehensive and highly curated acute myeloid leukemia (AML) clinical databases…